112 related articles for article (PubMed ID: 32444127)
1. Toll-Like 4 Receptor Expression on Peripheral Blood Mononuclear Cells in Renal Transplant Recipients Can Help to Indicate the Risk of Graft Deterioration in Patients Who Experienced an Episode of Symptomatic Cytomegalovirus Infection.
Zmonarski SC; Banasik M; Gołębiowski T; Letachowicz K; Madziarska K; Żabińska M; Zmonarska J; Mazanowska O; Krajewska M
Transplant Proc; 2020 Oct; 52(8):2394-2402. PubMed ID: 32444127
[TBL] [Abstract][Full Text] [Related]
2. Toll-like 4 receptor (TLR4) expression on peripheral blood mononuclear cells in renal transplant recipients with pre-transplant chronic interstitial nephritis indicates patients at risk of graft deterioration.
Zmonarski SC; Banasik M; Golebiowski T; Madziarska K; Mazanowska O; Myszka M; Zmonarska J; Letachowicz K; Dawiskiba T; Krajewska M
Transpl Immunol; 2020 Oct; 62():101319. PubMed ID: 32693120
[TBL] [Abstract][Full Text] [Related]
3. Expression of PBMC TLR4 in Renal Graft Recipients Who Experienced Delayed Graft Function Reflects Dynamic Balance Between Blood and Tissue Compartments and Helps Select a Problematic Patient.
Zmonarski S; Madziarska K; Banasik M; Mazanowska O; Magott-Procelewska M; Hap K; Krajewska M
Transplant Proc; 2018; 50(6):1744-1749. PubMed ID: 30056893
[TBL] [Abstract][Full Text] [Related]
4. Can the Toll-like receptors 4 expression in peripheral blood mononuclear cells help assess the effectiveness of immunosuppression and the chance of a future good renal transplant function?
Zmonarski SC; Madziarska K; Golebiowski T; Banasik M; Mazanowska O; Madziarski M; Krajewska M
Transpl Immunol; 2019 Apr; 53():43-50. PubMed ID: 30592973
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors associated with cytomegalovirus infection after the treatment of acute rejection during the first year in kidney transplant recipients receiving preemptive therapy.
Felipe C; Ferreira AN; de Paula M; Viana L; Cristelli M; Medina Pestana J; Tedesco-Silva H
Transpl Infect Dis; 2019 Dec; 21(6):e13106. PubMed ID: 31081566
[TBL] [Abstract][Full Text] [Related]
6. Early cytomegalovirus-specific T-cell response and estimated glomerular filtration rate identify patients at high risk of infection after renal transplantation.
Leone F; Gigliotti P; Mauro MV; Lofaro D; Greco F; Tenuta R; Perugini D; Papalia T; Mollica A; Perri A; Vizza D; La Russa A; Toteda G; Lupinacci S; Giraldi C; Bonofiglio R
Transpl Infect Dis; 2016 Apr; 18(2):191-201. PubMed ID: 26878346
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: Outcome and risk factors for late CMV disease.
Reusing JO; Feitosa EB; Agena F; Pierrotti LC; Azevedo LSF; Kotton CN; David-Neto E
Transpl Infect Dis; 2018 Oct; 20(5):e12929. PubMed ID: 29809309
[TBL] [Abstract][Full Text] [Related]
8. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients.
Vu D; Shah T; Ansari J; Sakharkar P; Yasir Q; Naraghi R; Hutchinson I; Min D
Transpl Infect Dis; 2014 Oct; 16(5):724-32. PubMed ID: 25208755
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of Different Valgancyclovir Formulations in the Universal 6-Month Prophylaxis Against CMV Infection in Renal Transplant Recipients: A Randomized Single-Centre Study.
Basic-Jukic N; Furic-Cunko V; Hudolin T; Zimak Z; Kirincich J; Kastelan Z
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Dec; 40(3):47-55. PubMed ID: 32109215
[TBL] [Abstract][Full Text] [Related]
11. A high level of urinary retinol-binding protein is associated with cytomegalovirus infection in kidney transplantation.
Requião-Moura LR; Matos ACC; Ozaki KS; Câmara NOS; Pacheco-Silva A
Clin Sci (Lond); 2018 Sep; 132(18):2059-2069. PubMed ID: 30171051
[TBL] [Abstract][Full Text] [Related]
12. Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients.
Hasegawa J; Hatakeyama S; Wakai S; Omoto K; Okumi M; Tanabe K; Mieno M; Shirakawa H
Int J Infect Dis; 2017 Dec; 65():50-56. PubMed ID: 28986314
[TBL] [Abstract][Full Text] [Related]
13. KIR and Human Leukocyte Antigen Genotype Associated Risk of Cytomegalovirus Disease in Renal Transplant Patients.
Michelo CM; van der Meer A; Tijssen HJ; Zomer R; Stelma F; Hilbrands LB; Joosten I
Transplantation; 2015 Jul; 99(7):1506-13. PubMed ID: 25427165
[TBL] [Abstract][Full Text] [Related]
14. Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia.
Knight RJ; Graviss EA; Nguyen DT; Kuten SA; Patel SJ; Gaber L; Gaber AO
Clin Transplant; 2018 Jun; 32(6):e13265. PubMed ID: 29676018
[TBL] [Abstract][Full Text] [Related]
15. High human cytomegalovirus DNAemia early post-transplantation associates with irreversible and progressive loss of renal function - a retrospective study.
Lollinga WT; Rurenga-Gard L; van Doesum W; van Bergen R; Diepstra A; Vonk JM; Riezebos-Brilman A; Niesters HGM; van Son WJ; van den Born J; Sanders JS
Transpl Int; 2017 Aug; 30(8):817-826. PubMed ID: 28432714
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus infection in renal transplant recipients: one center's experience.
Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients.
Lee YM; Kim YH; Han DJ; Park SK; Park JS; Sung H; Hong HL; Kim T; Kim SH; Choi SH; Kim YS; Woo JH; Lee SO
Transpl Infect Dis; 2014 Jun; 16(3):397-402. PubMed ID: 24810355
[TBL] [Abstract][Full Text] [Related]
18. Impact of cytomegalovirus infection on gene expression profile in heart transplant recipients.
Kanwar MK; Khush KK; Pinney S; Sherman C; Hall S; Teuteberg J; Uriel N; Kobashigawa J
J Heart Lung Transplant; 2021 Feb; 40(2):101-107. PubMed ID: 33341360
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis.
Stevens DR; Sawinski D; Blumberg E; Galanakis N; Bloom RD; Trofe-Clark J
Transpl Infect Dis; 2015 Apr; 17(2):163-73. PubMed ID: 25661673
[TBL] [Abstract][Full Text] [Related]
20. Relationship between toll-like receptor 2 Arg677Trp and Arg753Gln and toll-like receptor 4 Asp299Gly polymorphisms and cytomegalovirus infection.
Jabłońska A; Paradowska E; Studzińska M; Suski P; Nowakowska D; Wiśniewska-Ligier M; Woźniakowska-Gęsicka T; Wilczyński J; Leśnikowski ZJ
Int J Infect Dis; 2014 Aug; 25():11-5. PubMed ID: 24813591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
